Preoperative Pulmonary Function Tests in COPD Patients Posted For Major Upper Abdominal Surgeries: Evaluation of Postoperative Pulmonary Complications
Preoperative Pulmonary Function Tests in COPD Patients Posted For Major Surgeries
DOI:
https://doi.org/10.70284/njirm.v8i3.1239Keywords:
Chronic pulmonary obstructive disease, pulmonary function test, post operative outcomeAbstract
Background & aims: Pulmonary complications are a major cause of morbidity and mortality during the post-operative period after major upper abdominal surgeries. The incidence of post-operative pulmonary complications has been reported to vary between 5% and 80%. Incidences vary between hospitals. Various factors affect postoperative pulmonary outcome. So our aim was to study various possible factors (Gender, age, PFT finding, type of anaesthesia) which have impact on post operative pulmonary outcome. Method: This retrospective study was conducted at our hospital to evaluate the incidence of postoperative pulmonary complications (PPC) in patients with chronic obstructive pulmonary disease (COPD) and altered pulmonary function tests that underwent elective major upper abdominal surgery. Incidences of PPC were studied in relation to gender, age, type of anaesthesia, smoking and PFT findings. In our study, 45 adult COPD patients with altered PFT (FEV1/FVC< 88% of predicted for women and < 89% of predicted for men) were included whose entire post-operative period until discharge was observed from record. Result: Among them, 20% of patients were experienced PPC in form of bronchospasm (8.88%), prolonged intubation and mechanical ventilation (4.44%), pneumonia (4.44%), acute respiratory insufficiency (2.22%). Risk factors for PPC were male gender, elderly (>65years), low FEV1/FVC (71.9 +10.9%), general anaesthesia. No significant differences were found for co-morbidity (COPD) and abnormal lung function test between patients with or without PPC. In our study none of patients was having severe respiratory symptoms before operation. Surgical duration for all patients was less than 180 minutes. Patients with PPC had longer hospital stays (16.6 +15.0 vs. 7.5 + 5.7 days) and stayed longer in surgical intensive care units (7.0 + 5.9 vs. 1.7 + 0.7 days) than did those with no complications (p < 0.05). Conclusion: The incidence of PPC was not statistically significant in COPD patients with altered PFTs who were undergone elective major upper abdominal surgeries. [Ushma S NJIRM 2017; 8(3):26-29]
References
2. Fisher BW, Majumdar SR, McAlister FA. Predicting pulmonary complications after nonthoracic surgery: A systematic review of blinded studies. Am J Med 2002; 112:219-25.
3. Tisi GM. Preoperative evaluation of pulmonary function - Validity, indications and benefits. Am Rev Respir Dis 1979; 119: 293- 310.
4. Wightman JAK. To prospective survery of the incidence of postoperative pulmonary complications. Br J Surg 1968; 55: 85-91.
5. Pereira EDB, Faresin SM, Julian, and Fernandes ALG. Risk factors for pulmonary complications in postoperative period of upper abdominal lsurgery. J Pneumol 1996; 22: 19-26.
6. Wong DH, Weber EC, Schell MJ, Wong AB, Anderson CT, Barker SJ. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease. Anesth Analg 1995; 80: 276-284.
7. Stein M, Cassara The. Preoperative pulmonary evaluation and therapy for surgery patients. JAMA 1970; 211: 787-790.
8. Jackson CV. Preoperative pulmonary evaluation. Arch Intern Med1973; 148: 2120-2126.
9. Willians-Russo P, Charlson ME, Mackensie R, Gold JP. Predicting postoperative pulmonary complications. Arch Intern Med 1992; 152: 1209-1213.
10. Aldren CP, Barr LC, Leach RD. Hypoxaemia and postoperative pulmonary complications. Br J Surg 1991; 78: 1307-1308.
11. Hall JC, Tarala RA, Hall JL, Mander J. A multivariate analysis of the risk of pulmonary complications after laparotomy. Chest 1991; 99: 923-927.
12. Latimer RG, Dickman M, Day WC, Gunn ML, Schmidt CD. Ventilatory patterns and pulmonary complications after upper abdominal surgery determined by preoperative and postoperative computerized spirometry and gas analysis. Am J Surg 1971; 122:622-632.
13. Tarhan S, Moffitt EA, Sessler AD. Risk of anesthesia and surgery in patients with chronic obstructive pulmonary disease. Surgery1973; 74: 720-726.
14. Gold MI, Schwam SJ, Goldberg M. Chronic obstructive pulmonary disease and respiratory complications. Anesth Analg 1983; 62: 975-981.
15. Milledge JS, Nunn JF. Criteria of fitness for anaesthesia in patients with chronic obstructive lung disease. Br Med J 1975; 3: 670-673.
16. Kroenke K, Lawrence VA, Theroux JF, Tuley MR. Operative risk in patients with severe obstructive pulmonary disease. Arch Intern Med 1992; 152: 967-971.
17. Gracey DR, Divertie MB, Didier EB. Preoperative pulmonary preparation of patients with chronic obstructive pulmonary disease –A prospective study. Chest 1979; 76: 123-129.
18. Kroenke K, Lawrence VA, Theroux JF, Tuley MR, Hilsenbeck S. Postoperative complications after thoracic and major abdominal surgery in patients with and without obstructive lung disease. Chest 1993; 104: 1445-1451.
19. Garibaldi RA; Britt MR, Coleman ML, Reading JC, Pace NL. Risk factors for postoperative pneumonia. Am J Med 1981; 70: 677-680.
20. American Society of Anesthesiologists. New classification of physical status. Anesthesiology 1963; 24: 111.
21. Shapiro BA, Harrison RA, Kacmarek RM, Cane RD. Clinical application of respiratory care. Chicago: Year Book Medical Publishers, 1985; 518.
22. Hall JC, Tarala R, Harris J, Christiansen K. Incentive spirometry versus routine chest physiotherapy for prevention of pulmonary complications after abdominal surgery. Lancet 1991; 337: 953-956.
23. Chuter AM, Weissman C, Starker PM, Gump FE. Effect of incentive spirometry on diaphragmatic function after surgery. Surgery 1989; 105: 488-492.
24. Celli BR. Perioperative respiratory care of the patient undergoing upper abdominal surgery. Clin Chest Med 1993; 14: 253-262.
25. Warner MA, Divertie MB, Tinker JH. Preoperative cessation of smoking and pulmonary complications in coronary artery bypass patients. Anaesthesiology 1984; 60: 380-383.
26. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Circulation 1996; 93: 2212-2245.
27. Frankel HM. Determination of body mass index. JAMA 1986; 255: 1292.
28. World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee. Ginebra: OMS, 1995; CapÃtulo 8: 345-374.
29. Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P et al. Consensus Statement. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
30. Williams CD, Brenowitz JB. “Prohibitive†lung function and major surgical procedures. Am J Surg 1976; 132: 763-766.
31. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease: state of the art. Am Rev Respir Dis 1992; 146: 1067-1083.
32. Cohen A, Katz M, Katz R, Hauptman E, Schachner A. Chronic obstructive pulmonary disease in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1995; 109: 574- 581.
33. Svensson LG, Hess KR, Coselli JS. A prospective study of respiratory failure after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg 1991; 14: 271-282.
34. Money SR, Rice K, Crockett D, Becker M, Abdoh A, Wisseink W et al. Risk of respiratory failure after repair of thoracoabdominal aortic aneurysms. Am J Surg 1994; 168: 152-155.
35. Siegel S, Castellan NJ Jr. Nonparametrics statistics (2n ed). Nueva York: McGraw-Hill, 1998; 399.
